Asymptomatic HIV testing in Villafranca in Lunigiana

Find health labs to test for Asymptomatic HIV in Villafranca in Lunigiana and compare all offers by prices and services.

Tests that cover Asymptomatic HIV

HIV Test
test epatite B, epatite C, HIV con autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€60.00

€57.00 with our promocode

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Paolo Borsellino, 1 43029 Traversetolo (PR)

32.1 km

Unverified

See Details

Rapid HIV Test by Farmacia Minerva s.n.c

Strada Langhirano, 34, 43124 Parma PR, Italia

39.8 km

Unverified

See Details

HIV Test by Bianalisi - Punto prelievo Rapallo

Via Pellerano Murtula, 1, 16035 Rapallo GE, Italia

35.8 km

Unverified

See Details

HIV Test by Farmacia San Terenziano

Via Don P. Tesauri, 2, 42025 Cavriago RE, Italia

39.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Emilia Est, 144 43123 Parma (PR)

39.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Vastato, 44/1 16036 Recco (GE)

40.2 km

Unverified

See Details

HIV Test by Laboratorio Lifebrain

Viale Bottego, 3 43121 Parma (PR)

39.8 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Goffredo Mameli, 15 42123 Reggio Emilia (RE)

43.6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Monte San Michele, 5/D 42121 Reggio Emilia (RE)

43.6 km

Unverified

See Details

Rapid HIV Test by Laboratorio Lifebrain

Via Guglielmo Marconi, 28 43058 Sorbolo (PR)

45.3 km

Unverified

See Details

Asymptomatic HIV - symptoms and how to test

The second stage of HIV/AIDS involves infection without symptoms. At this time, HIV infection shows no visible symptoms. Patients often seek medical treatment due to symptoms; therefore, asymptomatic infections frequently go undetected. According to an estimate, around 10-60 % of individuals with early HIV infection will not experience symptoms. Patients who are asymptomatic but have HIV infection might benefit from therapies to lower their risk of clinical events and disease transmission if tested and found to have the virus.